Description
Tenovin-3, like other tenovins, may activate p53 or inhibit SIRT2.
Product Unit Size | Cost | Quantity | Stock |
---|
Tenovin-3, like other tenovins, may activate p53 or inhibit SIRT2.
Cas No. | 1011301-27-1 |
---|---|
Purity | ≥98% |
Formula | C18H21N3OS |
Formula Wt. | 327.45 |
IUPAC Name | N-[(4-Aminophenyl)carbamothioyl]-4-(2-methyl-2-propanyl)benzamide |
Solubility | DMSO: ≥ 31 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Dogra S, Bandi S, Viswanathan P, et al. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma. Cancer Lett. 2015 Jan 28;356(2 Pt B):953-61. PMID: 25444910.
Sonnemann J, Marx C, Becker S, et al. p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors.Br J Cancer. 2014 Feb 4;110(3):656-67. PMID: 24281001.
Islet α/β cell proliferation stimulator.
PDE3 inhibitor.
Protease inhibitor.
STING inhibitor
11β-HSD1 inhibitor.
Histamine H1 antagonist, FIASMA.
Endogenous bombesin-like peptide, involved in f...
Peptide, neurotensin analog.
Peptide; α4β1 integrin activator.
Inhibitor of EGFR, HER2, VEGFR2, and FLT3.
Oxazolidone derivative; Factor Xa inhibitor.
Antioxidant.
PI3K and PDK1 inhibitor.
Bisphosphonate, chelating agent.
Geldanamycin derivative; HSP90 inhibitor.
EZH2 HMT inhibitor.
Protease inhibitor.
NPC1L1 inhibitor.
PRMT5 inhibitor
Peptide, confers resistance against macrolide a...